127 related articles for article (PubMed ID: 27687589)
1. Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice.
Pyo KH; Lee YW; Lim SM; Shin EH
Oncotarget; 2016 Nov; 7(45):74107-74119. PubMed ID: 27687589
[TBL] [Abstract][Full Text] [Related]
2. The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties.
Hedhli D; Moiré N; Akbar H; Laurent F; Héraut B; Dimier-Poisson I; Mévélec MN
Med Microbiol Immunol; 2016 Aug; 205(4):345-52. PubMed ID: 26935827
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.
Ge Y; Chen J; Qiu X; Zhang J; Cui L; Qi Y; Liu X; Qiu J; Shi Z; Lun Z; Shen J; Wang Y
Int J Parasitol; 2014 Jun; 44(7):475-84. PubMed ID: 24727091
[TBL] [Abstract][Full Text] [Related]
5. Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.
Gableh F; Saeidi M; Hemati S; Hamdi K; Soleimanjahi H; Gorji A; Ghaemi A
J Biomed Sci; 2016 Jan; 23():16. PubMed ID: 26811064
[TBL] [Abstract][Full Text] [Related]
6. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
8. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.
Li XZ; Lv L; Zhang X; Anchang KY; Abdullahi AY; Tu L; Wang X; Xia L; Zhang XX; Feng W; Lu C; Li S; Yuan ZG
Infect Genet Evol; 2016 Nov; 45():447-453. PubMed ID: 27742446
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.
Wagner A; Schabussova I; Ruttkowski B; Peschke R; Kur J; Kundi M; Joachim A; Wiedermann U
PLoS One; 2015; 10(5):e0126334. PubMed ID: 26010355
[TBL] [Abstract][Full Text] [Related]
10. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
[TBL] [Abstract][Full Text] [Related]
11. Structure-based analysis of Toxoplasma gondii profilin: a parasite-specific motif is required for recognition by Toll-like receptor 11.
Kucera K; Koblansky AA; Saunders LP; Frederick KB; De La Cruz EM; Ghosh S; Modis Y
J Mol Biol; 2010 Nov; 403(4):616-29. PubMed ID: 20851125
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with profilin encapsulated in oligomannose-coated liposomes induces significant protective immunity against Toxoplasma gondii.
Tanaka S; Kuroda Y; Ihara F; Nishimura M; Hiasa J; Kojima N; Nishikawa Y
Vaccine; 2014 Apr; 32(16):1781-5. PubMed ID: 24530937
[TBL] [Abstract][Full Text] [Related]
14. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection.
Jang SI; Lillehoj HS; Lee SH; Lee KW; Park MS; Bauchan GR; Lillehoj EP; Bertrand F; Dupuis L; Deville S
Vet Parasitol; 2010 Sep; 172(3-4):221-8. PubMed ID: 20541870
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection.
Wang HL; Pang M; Yin LT; Zhang JH; Meng XL; Yu BF; Guo R; Bai JZ; Zheng GP; Yin GR
Acta Trop; 2014 Sep; 137():58-66. PubMed ID: 24813415
[TBL] [Abstract][Full Text] [Related]
16. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response.
Yarovinsky F; Kanzler H; Hieny S; Coffman RL; Sher A
Immunity; 2006 Oct; 25(4):655-64. PubMed ID: 17000122
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor recognition of Toxoplasma gondii.
Yarovinsky F; Sher A
Int J Parasitol; 2006 Mar; 36(3):255-9. PubMed ID: 16476433
[TBL] [Abstract][Full Text] [Related]
19. Mixture of Alum--Naloxone and Alum--Naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB /c mice.
Khorshidvand Z; Shahabi S; Mohamadzade H; Daryani A; Hazrati Tappeh K
Exp Parasitol; 2016 Mar; 162():28-34. PubMed ID: 26773164
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
